ClinConnect ClinConnect Logo

Main Menu

Search for Trials
Browse by Condition
For Industry
Blog
Contact Us
Dark Mode
Log in Sign up

Clinical Trials in Cullman, Alabama

Find clinical trials in Cullman, Alabama. Discover local research opportunities and treatment options in your area.

13 Active Trials Found in Cullman

Showing 13 trials on this page

Page 1 of 1

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

NCT ID: NCT05877963

This clinical trial is studying a modified treatment approach using a drug called ublituximab for people with relapsing multiple sclerosis (RMS). The main goal is to see how effective this new regi...

Recruiting
Phase: PHASE3 Conditions: Relapsing Multiple Sclerosis

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

NCT ID: NCT06878261

This clinical trial is investigating a medication called Tezepelumab to see how well it works and how safe it is for adults with moderate to very severe Chronic Obstructive Pulmonary Disease (COPD)...

Recruiting
Phase: PHASE3 Conditions: Chronic Obstructive Pulmonary Disease (COPD)

A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes

NCT ID: NCT07076199

This clinical trial is studying a new type of insulin called insulin icodec, which is taken once a week, to see how well it controls blood sugar compared to the usual daily insulin called insulin g...

Recruiting
Phase: PHASE3 Conditions: Diabetes Mellitus, Type 1

A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)

NCT ID: NCT06455202

This clinical trial is studying a new treatment called barzolvolimab for adults suffering from Chronic Spontaneous Urticaria (CSU), which is a condition where people experience itchy hives without ...

Recruiting
Phase: PHASE3 Conditions: Chronic Spontaneous Urticaria

Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy

NCT ID: NCT06619860

This clinical trial is studying a new treatment called VX-993 to see how well it works and how safe it is for people suffering from pain caused by Diabetic Peripheral Neuropathy (DPN). DPN is a typ...

Recruiting
Phase: PHASE2 Conditions: Diabetic Peripheral Neuropathic Pain

Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)

NCT ID: NCT06098079

This clinical trial is studying the effects of a medication combination called naltrexone and bupropion (marketed as Contrave® or Mysimba®) on heart-related events in people with obesity. The goal ...

Recruiting
Phase: PHASE4 Conditions: Obesity

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

NCT ID: NCT06283966

This clinical trial is studying a new inhaler that combines three medications—budesonide, glycopyrronium, and formoterol—to see how well it works in improving heart and lung health in people with C...

Recruiting
Phase: PHASE3 Conditions: COPD (Chronic Obstructive Pulmonary Disease)

A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation

NCT ID: NCT05090371

This clinical trial is studying whether patients with relapsing-remitting multiple sclerosis (MS) who have not experienced a relapse in the past year would benefit from switching to a medication ca...

Recruiting
Phase: PHASE4 Conditions: Relapsing-Remitting Multiple Sclerosis

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

NCT ID: NCT06141473

This clinical trial is studying the effectiveness and safety of a medication called frexalimab (also known as SAR441344) for adults who have relapsing forms of multiple sclerosis (MS). The goal is ...

Recruiting
Phase: PHASE3 Conditions: Multiple Sclerosis

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

NCT ID: NCT06667700

This clinical trial is studying a medication called molnupiravir to see if it can help prevent severe illness from COVID-19 in people who are at high risk. COVID-19 usually causes mild symptoms, bu...

Recruiting
Phase: PHASE3 Conditions: Coronavirus Disease (COVID-19)

Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma

NCT ID: NCT05097287

This clinical trial is exploring how well a medication called dupilumab can help prevent lung function decline in adults who have moderate to severe asthma that isn't well controlled. The study wil...

Recruiting
Phase: PHASE4 Conditions: Asthma

A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.

NCT ID: NCT06372145

This clinical trial is investigating the long-term safety and tolerability of a medication called tolebrutinib for adults with different types of Multiple Sclerosis (MS), including relapsing forms ...

Recruiting
Phase: PHASE3 Conditions: Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis +1 more

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

NCT ID: NCT06926842

This clinical trial, called ZUPREME 2, is looking at a new medication called petrelintide to see if it can help people who are overweight or obese and have type 2 diabetes. The study will compare d...

Recruiting
Phase: PHASE2 Conditions: Obesity, Type 2 Diabetes +1 more
Search All Trials Browse All Locations